2.50
Hdl Handle:
http://hdl.handle.net/10755/162810
Type:
Presentation
Title:
Assessment of an Emergency Department Rhogam Protocol
Abstract:
Assessment of an Emergency Department Rhogam Protocol
Conference Sponsor:Emergency Nurses Association
Conference Year:1997
Author:Meunier-Sham, Joan, RN, MSN, CEN
Contact Address:, USA
Co-Authors:Susan D. Fish
Clinical Topic: Prevention of autoimmunization of Rh (-) women following TABs, SABs, Threatened Abs and ectopic pregnancies is substantially reduced through the administration of D immunoglobulin (Rhogam) within 72 hours of blood exposure. Compliance with a collaborative/MD protocol that identifies and treats RH (-) women with Rhogam (RN identifies patients and sends Type and Screen, RN/MD reviews Rh status and, MD orders Rhogam PRN) was studied.

Process of Implementation: All patients having an Emergency DEPARTMENT D&E in an inner city Level 1 trauma center were identified (Group A). Additionally, a subgroup of patients with the diagnoses SAB, Threatened AB and r/o ectopic pregnancy were identified (Group B). Charts were reviewed at least weekly and the computer was checked to verify each patientÆs Rh status. Group A and B were compared using Chi Square.

Outcomes: Nursing documentation indicated that a Type and Screen was sent in 47/77 (61%) of Group A and 26/51 (51%) of Group B (p>.05). MDs documented Rh status in 32/77 (42%) of Group A and 17/51 (33%) of Group A and 44/51 (86%) of Group B 9p=.0008). Eight percent (6/77) of Group A patients were Rh (-) and twelve percent (5/43) of Group B patients were Rh (-). One hundred percent (6/6) sixty percent (3/5) of Group B were treated with Rhogam in the ED. One of the untreated women received Rhogam within 72 hours prior to a TAB and the other was contacted and informed of the need to notify her OB/GYN.

Recommendations for Clinical Practice: D&E patients received more complete treatment than patients not requiring a therapeutic procedure in the ED. Recommendations for clinical practice include on-going continuous quality improvement (CQI) activities focused on documentation as well as appropriateness and timeliness of treatment for all Rh (-) women with actual or threatened pregnancy loss. [Clinical Poster Presentation]
Repository Posting Date:
27-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Emergency Nurses Association

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleAssessment of an Emergency Department Rhogam Protocolen_GB
dc.identifier.urihttp://hdl.handle.net/10755/162810-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Assessment of an Emergency Department Rhogam Protocol</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Emergency Nurses Association</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">1997</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Meunier-Sham, Joan, RN, MSN, CEN</td></tr><tr class="item-address"><td class="label">Contact Address:</td><td class="value">, USA</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">res@ena.org</td></tr><tr class="item-co-authors"><td class="label">Co-Authors:</td><td class="value">Susan D. Fish</td></tr><tr><td colspan="2" class="item-abstract">Clinical Topic: Prevention of autoimmunization of Rh (-) women following TABs, SABs, Threatened Abs and ectopic pregnancies is substantially reduced through the administration of D immunoglobulin (Rhogam) within 72 hours of blood exposure. Compliance with a collaborative/MD protocol that identifies and treats RH (-) women with Rhogam (RN identifies patients and sends Type and Screen, RN/MD reviews Rh status and, MD orders Rhogam PRN) was studied.<br/><br/>Process of Implementation: All patients having an Emergency DEPARTMENT D&amp;E in an inner city Level 1 trauma center were identified (Group A). Additionally, a subgroup of patients with the diagnoses SAB, Threatened AB and r/o ectopic pregnancy were identified (Group B). Charts were reviewed at least weekly and the computer was checked to verify each patient&AElig;s Rh status. Group A and B were compared using Chi Square.<br/><br/>Outcomes: Nursing documentation indicated that a Type and Screen was sent in 47/77 (61%) of Group A and 26/51 (51%) of Group B (p&gt;.05). MDs documented Rh status in 32/77 (42%) of Group A and 17/51 (33%) of Group A and 44/51 (86%) of Group B 9p=.0008). Eight percent (6/77) of Group A patients were Rh (-) and twelve percent (5/43) of Group B patients were Rh (-). One hundred percent (6/6) sixty percent (3/5) of Group B were treated with Rhogam in the ED. One of the untreated women received Rhogam within 72 hours prior to a TAB and the other was contacted and informed of the need to notify her OB/GYN.<br/><br/>Recommendations for Clinical Practice: D&amp;E patients received more complete treatment than patients not requiring a therapeutic procedure in the ED. Recommendations for clinical practice include on-going continuous quality improvement (CQI) activities focused on documentation as well as appropriateness and timeliness of treatment for all Rh (-) women with actual or threatened pregnancy loss. [Clinical Poster Presentation]</td></tr></table>en_GB
dc.date.available2011-10-27T10:34:32Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-27T10:34:32Z-
dc.description.sponsorshipEmergency Nurses Associationen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.